Multipotency and cardiomyogenic potential of human adipose-derived stem cells from epicardium, pericardium, and omentum

Acute myocardial infarction (MI) leads to an irreversible loss of proper cardiac function. Application of stem cell therapy is an attractive option for MI treatment. Adipose tissue has proven to serve as a rich source of stem cells (ADSCs). Taking into account the different morphogenesis, anatomy, a...

Full description

Saved in:
Bibliographic Details
Published inStem cell research & therapy Vol. 7; no. 1; p. 84
Main Authors Wystrychowski, Wojciech, Patlolla, Bhagat, Zhuge, Yan, Neofytou, Evgenios, Robbins, Robert C., Beygui, Ramin E.
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 13.06.2016
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Acute myocardial infarction (MI) leads to an irreversible loss of proper cardiac function. Application of stem cell therapy is an attractive option for MI treatment. Adipose tissue has proven to serve as a rich source of stem cells (ADSCs). Taking into account the different morphogenesis, anatomy, and physiology of adipose tissue, we hypothesized that ADSCs from different adipose tissue depots may exert a diverse multipotency and cardiogenic potential. The omental, pericardial, and epicardial adipose tissue samples were obtained from organ donors and patients undergoing heart transplantation at our institution. Human foreskin fibroblasts were used as the control group. Isolated ADSCs were analyzed for adipogenic and osteogenic differentiation capacity and proliferation potential. The immunophenotype and constitutive gene expression of alkaline phosphatase (ALP), GATA4, Nanog, and OCT4 were analyzed. DNA methylation inhibitor 5-azacytidine was exposed to the cells to stimulate the cardiogenesis. Finally, reprogramming towards cardiomyocytes was initiated with exogenous overexpression of seven transcription factors (ESRRG, GATA4, MEF2C, MESP1, MYOCD, TBX5, ZFPM2) previously applied successfully for fibroblast transdifferentiation toward cardiomyocytes. Expression of cardiac troponin T (cTNT) and alpha-actinin (Actn2) was analyzed 3 weeks after initiation of the cardiac differentiation. The multipotent properties of isolated plastic adherent cells were confirmed with expression of CD29, CD44, CD90, and CD105, as well as successful differentiation toward adipocytes and osteocytes; with the highest osteogenic and adipogenic potential for the epicardial and omental ADSCs, respectively. Epicardial ADSCs demonstrated a lower doubling time as compared with the pericardium and omentum-derived cells. Furthermore, epicardial ADSCs revealed higher constitutive expression of ALP and GATA4. Increased Actn2 and cTNT expression was observed after the transduction of seven reprogramming factors, with the highest expression in the epicardial ADSCs, as compared with the other ADSC subtypes and fibroblasts. Human epicardial ADSCs revealed a higher cardiomyogenic potential as compared with the pericardial and omental ADSC subtypes as well as the fibroblast counterparts. Epicardial ADSCs may thus serve as the valuable subject for further studies on more effective methods of adult stem cell differentiation toward cardiomyocytes.
AbstractList Acute myocardial infarction (MI) leads to an irreversible loss of proper cardiac function. Application of stem cell therapy is an attractive option for MI treatment. Adipose tissue has proven to serve as a rich source of stem cells (ADSCs). Taking into account the different morphogenesis, anatomy, and physiology of adipose tissue, we hypothesized that ADSCs from different adipose tissue depots may exert a diverse multipotency and cardiogenic potential. The omental, pericardial, and epicardial adipose tissue samples were obtained from organ donors and patients undergoing heart transplantation at our institution. Human foreskin fibroblasts were used as the control group. Isolated ADSCs were analyzed for adipogenic and osteogenic differentiation capacity and proliferation potential. The immunophenotype and constitutive gene expression of alkaline phosphatase (ALP), GATA4, Nanog, and OCT4 were analyzed. DNA methylation inhibitor 5-azacytidine was exposed to the cells to stimulate the cardiogenesis. Finally, reprogramming towards cardiomyocytes was initiated with exogenous overexpression of seven transcription factors (ESRRG, GATA4, MEF2C, MESP1, MYOCD, TBX5, ZFPM2) previously applied successfully for fibroblast transdifferentiation toward cardiomyocytes. Expression of cardiac troponin T (cTNT) and alpha-actinin (Actn2) was analyzed 3 weeks after initiation of the cardiac differentiation. The multipotent properties of isolated plastic adherent cells were confirmed with expression of CD29, CD44, CD90, and CD105, as well as successful differentiation toward adipocytes and osteocytes; with the highest osteogenic and adipogenic potential for the epicardial and omental ADSCs, respectively. Epicardial ADSCs demonstrated a lower doubling time as compared with the pericardium and omentum-derived cells. Furthermore, epicardial ADSCs revealed higher constitutive expression of ALP and GATA4. Increased Actn2 and cTNT expression was observed after the transduction of seven reprogramming factors, with the highest expression in the epicardial ADSCs, as compared with the other ADSC subtypes and fibroblasts. Human epicardial ADSCs revealed a higher cardiomyogenic potential as compared with the pericardial and omental ADSC subtypes as well as the fibroblast counterparts. Epicardial ADSCs may thus serve as the valuable subject for further studies on more effective methods of adult stem cell differentiation toward cardiomyocytes.
Acute myocardial infarction (MI) leads to an irreversible loss of proper cardiac function. Application of stem cell therapy is an attractive option for MI treatment. Adipose tissue has proven to serve as a rich source of stem cells (ADSCs). Taking into account the different morphogenesis, anatomy, and physiology of adipose tissue, we hypothesized that ADSCs from different adipose tissue depots may exert a diverse multipotency and cardiogenic potential. The omental, pericardial, and epicardial adipose tissue samples were obtained from organ donors and patients undergoing heart transplantation at our institution. Human foreskin fibroblasts were used as the control group. Isolated ADSCs were analyzed for adipogenic and osteogenic differentiation capacity and proliferation potential. The immunophenotype and constitutive gene expression of alkaline phosphatase (ALP), GATA4, Nanog, and OCT4 were analyzed. DNA methylation inhibitor 5-azacytidine was exposed to the cells to stimulate the cardiogenesis. Finally, reprogramming towards cardiomyocytes was initiated with exogenous overexpression of seven transcription factors (ESRRG, GATA4, MEF2C, MESP1, MYOCD, TBX5, ZFPM2) previously applied successfully for fibroblast transdifferentiation toward cardiomyocytes. Expression of cardiac troponin T (cTNT) and alpha-actinin (Actn2) was analyzed 3 weeks after initiation of the cardiac differentiation. The multipotent properties of isolated plastic adherent cells were confirmed with expression of CD29, CD44, CD90, and CD105, as well as successful differentiation toward adipocytes and osteocytes; with the highest osteogenic and adipogenic potential for the epicardial and omental ADSCs, respectively. Epicardial ADSCs demonstrated a lower doubling time as compared with the pericardium and omentum-derived cells. Furthermore, epicardial ADSCs revealed higher constitutive expression of ALP and GATA4. Increased Actn2 and cTNT expression was observed after the transduction of seven reprogramming factors, with the highest expression in the epicardial ADSCs, as compared with the other ADSC subtypes and fibroblasts. Human epicardial ADSCs revealed a higher cardiomyogenic potential as compared with the pericardial and omental ADSC subtypes as well as the fibroblast counterparts. Epicardial ADSCs may thus serve as the valuable subject for further studies on more effective methods of adult stem cell differentiation toward cardiomyocytes.
Background Acute myocardial infarction (MI) leads to an irreversible loss of proper cardiac function. Application of stem cell therapy is an attractive option for MI treatment. Adipose tissue has proven to serve as a rich source of stem cells (ADSCs). Taking into account the different morphogenesis, anatomy, and physiology of adipose tissue, we hypothesized that ADSCs from different adipose tissue depots may exert a diverse multipotency and cardiogenic potential. Methods The omental, pericardial, and epicardial adipose tissue samples were obtained from organ donors and patients undergoing heart transplantation at our institution. Human foreskin fibroblasts were used as the control group. Isolated ADSCs were analyzed for adipogenic and osteogenic differentiation capacity and proliferation potential. The immunophenotype and constitutive gene expression of alkaline phosphatase (ALP), GATA4, Nanog, and OCT4 were analyzed. DNA methylation inhibitor 5-azacytidine was exposed to the cells to stimulate the cardiogenesis. Finally, reprogramming towards cardiomyocytes was initiated with exogenous overexpression of seven transcription factors (ESRRG, GATA4, MEF2C, MESP1, MYOCD, TBX5, ZFPM2) previously applied successfully for fibroblast transdifferentiation toward cardiomyocytes. Expression of cardiac troponin T (cTNT) and alpha-actinin (Actn2) was analyzed 3 weeks after initiation of the cardiac differentiation. Results The multipotent properties of isolated plastic adherent cells were confirmed with expression of CD29, CD44, CD90, and CD105, as well as successful differentiation toward adipocytes and osteocytes; with the highest osteogenic and adipogenic potential for the epicardial and omental ADSCs, respectively. Epicardial ADSCs demonstrated a lower doubling time as compared with the pericardium and omentum-derived cells. Furthermore, epicardial ADSCs revealed higher constitutive expression of ALP and GATA4. Increased Actn2 and cTNT expression was observed after the transduction of seven reprogramming factors, with the highest expression in the epicardial ADSCs, as compared with the other ADSC subtypes and fibroblasts. Conclusions Human epicardial ADSCs revealed a higher cardiomyogenic potential as compared with the pericardial and omental ADSC subtypes as well as the fibroblast counterparts. Epicardial ADSCs may thus serve as the valuable subject for further studies on more effective methods of adult stem cell differentiation toward cardiomyocytes.
Background Acute myocardial infarction (MI) leads to an irreversible loss of proper cardiac function. Application of stem cell therapy is an attractive option for MI treatment. Adipose tissue has proven to serve as a rich source of stem cells (ADSCs). Taking into account the different morphogenesis, anatomy, and physiology of adipose tissue, we hypothesized that ADSCs from different adipose tissue depots may exert a diverse multipotency and cardiogenic potential. Methods The omental, pericardial, and epicardial adipose tissue samples were obtained from organ donors and patients undergoing heart transplantation at our institution. Human foreskin fibroblasts were used as the control group. Isolated ADSCs were analyzed for adipogenic and osteogenic differentiation capacity and proliferation potential. The immunophenotype and constitutive gene expression of alkaline phosphatase (ALP), GATA4, Nanog, and OCT4 were analyzed. DNA methylation inhibitor 5-azacytidine was exposed to the cells to stimulate the cardiogenesis. Finally, reprogramming towards cardiomyocytes was initiated with exogenous overexpression of seven transcription factors (ESRRG, GATA4, MEF2C, MESP1, MYOCD, TBX5, ZFPM2) previously applied successfully for fibroblast transdifferentiation toward cardiomyocytes. Expression of cardiac troponin T (cTNT) and alpha-actinin (Actn2) was analyzed 3 weeks after initiation of the cardiac differentiation. Results The multipotent properties of isolated plastic adherent cells were confirmed with expression of CD29, CD44, CD90, and CD105, as well as successful differentiation toward adipocytes and osteocytes; with the highest osteogenic and adipogenic potential for the epicardial and omental ADSCs, respectively. Epicardial ADSCs demonstrated a lower doubling time as compared with the pericardium and omentum-derived cells. Furthermore, epicardial ADSCs revealed higher constitutive expression of ALP and GATA4. Increased Actn2 and cTNT expression was observed after the transduction of seven reprogramming factors, with the highest expression in the epicardial ADSCs, as compared with the other ADSC subtypes and fibroblasts. Conclusions Human epicardial ADSCs revealed a higher cardiomyogenic potential as compared with the pericardial and omental ADSC subtypes as well as the fibroblast counterparts. Epicardial ADSCs may thus serve as the valuable subject for further studies on more effective methods of adult stem cell differentiation toward cardiomyocytes. Keywords: Adipose-derived stem cells, Mesenchymal stem cells, Reprogramming, Cardiogenesis, Adipose tissue, Epicardium, Pericardium, Cardiomyocytes, Fibroblasts, Alkaline phosphatase
ArticleNumber 84
Audience Academic
Author Patlolla, Bhagat
Zhuge, Yan
Wystrychowski, Wojciech
Beygui, Ramin E.
Neofytou, Evgenios
Robbins, Robert C.
Author_xml – sequence: 1
  givenname: Wojciech
  surname: Wystrychowski
  fullname: Wystrychowski, Wojciech
– sequence: 2
  givenname: Bhagat
  surname: Patlolla
  fullname: Patlolla, Bhagat
– sequence: 3
  givenname: Yan
  surname: Zhuge
  fullname: Zhuge, Yan
– sequence: 4
  givenname: Evgenios
  surname: Neofytou
  fullname: Neofytou, Evgenios
– sequence: 5
  givenname: Robert C.
  surname: Robbins
  fullname: Robbins, Robert C.
– sequence: 6
  givenname: Ramin E.
  surname: Beygui
  fullname: Beygui, Ramin E.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27296220$$D View this record in MEDLINE/PubMed
BookMark eNp1kl9r1TAchoNM3Jz7AN5IQBAGdiZpmrY3whhTBxPBP9chJ_n1nIwmOTbptN_edGcbp6LNRZvmeZ-G9H2ODnzwgNBLSs4obcS7SEvW1AWhoiAlL4vpCTqidVUXoqLsYO_5EJ3EeEPyVZaECP4MHbKatYIxcoR-fR77ZLchgdcTVt5grQZjg5vCGrzV-G4pWdXj0OHN6JTHyuRAhMLAYG_B4JjAYQ19H3E3BIdha-8ko3uLt5l5nMz64LJudC_Q0071EU7u78fox4fL7xefiusvH68uzq8LLViVCs5VJ0hZtSUFvqprgE6rVhvBmVlVmjAuQInWGN6ptuFKV2UpVm2rdc5VipTH6P3Oux1XDozOHx9UL7eDdWqYZFBWLle83ch1uJW8JTVrqix4fS8Yws8RYpI3YRx83rOkDSFNLUi1R61VD9L6LmSZdjZqec5F09QtZTN19g8qDwPO6vx7O5vfLwKni0BmEvxOazXGKK--fV2yb_bYDag-bWLox2SDj0vw1f6RPJ7FQykyUO8APYQYB-iktknNnrxd20tK5NxAuWugzA2UcwPllJP0r-SD_P-ZPzKb3mw
CitedBy_id crossref_primary_10_1007_s12015_020_10097_4
crossref_primary_10_1089_scd_2018_0232
crossref_primary_10_3390_pharmaceutics14112338
crossref_primary_10_1016_j_trsl_2022_10_004
crossref_primary_10_1016_j_addr_2020_04_003
crossref_primary_10_18632_aging_102491
crossref_primary_10_1016_j_addr_2017_09_005
crossref_primary_10_1186_s13287_019_1460_1
crossref_primary_10_3390_ani12162049
crossref_primary_10_3390_ijms25073901
crossref_primary_10_1038_s41598_019_47224_2
crossref_primary_10_1089_scd_2021_0297
crossref_primary_10_1038_s42003_021_02677_y
crossref_primary_10_3390_ani13081352
crossref_primary_10_1016_j_molimm_2017_03_020
crossref_primary_10_1139_cjpp_2023_0282
crossref_primary_10_1002_biof_1717
crossref_primary_10_3390_cells9020504
crossref_primary_10_1371_journal_pone_0187118
crossref_primary_10_1016_j_bbadis_2024_167223
crossref_primary_10_1155_2020_2830565
crossref_primary_10_3390_ijms21249598
crossref_primary_10_3389_fcvm_2021_709079
crossref_primary_10_1002_cbf_3610
crossref_primary_10_33988_auvfd_682682
crossref_primary_10_1111_jcmm_14456
crossref_primary_10_1186_s40035_021_00238_1
crossref_primary_10_1089_scd_2016_0334
crossref_primary_10_1093_burnst_tkac028
crossref_primary_10_1186_s13287_021_02509_0
crossref_primary_10_1063_5_0038101
crossref_primary_10_1016_j_bioactmat_2023_03_023
crossref_primary_10_1089_ten_teb_2023_0049
crossref_primary_10_3390_ijms25073583
crossref_primary_10_1089_jop_2023_0154
crossref_primary_10_1186_s40824_023_00419_1
Cites_doi 10.1038/sj.cr.7310116
10.1038/nature07060
10.1016/j.stem.2011.10.002
10.1161/CIR.0000000000000152
10.1161/01.CIR.0000151812.86142.45
10.1510/icvts.2007.157875
10.1186/1471-2407-14-90
10.1210/jc.2009-0571
10.1016/j.ydbio.2006.03.033
10.1016/j.scr.2007.06.001
10.1038/ncpcardio0319
10.1159/000474568
10.1001/jama.2012.25321
10.1172/JCI5298
10.1089/scd.2010.0519
10.1242/dev.124.12.2387
10.3390/jdb2020117
10.1161/ATVBAHA.109.191643
10.1016/j.ahj.2008.11.011
10.1016/j.carpath.2004.08.005
10.2337/dc10-0904
10.1016/j.scr.2014.06.005
10.1161/01.CIR.92.3.334
10.1016/S0140-6736(05)67861-0
10.1038/nature11044
10.1186/1477-5751-11-3
10.1016/j.ydbio.2004.08.008
10.1359/jbmr.1999.14.7.1115
10.1371/journal.pone.0115963
10.1016/0378-1119(94)00893-W
10.1016/S0002-9440(10)62041-X
10.1080/07853890500422982
10.1080/14653240600855905
10.1007/978-1-60327-169-1_7
10.1038/ncb1542
10.1186/s12860-014-0042-4
10.1128/MCB.14.11.7517
10.1161/CIRCULATIONAHA.111.047480
10.1016/j.cell.2010.07.002
10.3324/haematol.13699
10.1038/nature02446
10.1161/JAHA.113.000253
10.1002/stem.1285
10.1007/s00018-007-6522-3
10.1186/scrt481
10.1172/JCI45529
10.1038/nature11682
10.1016/j.ydbio.2006.03.036
10.1002/emmm.201201737
10.1016/0735-1097(93)90407-R
10.1016/S0140-6736(12)60195-0
10.1161/CIRCRESAHA.112.300567
10.1101/gad.11.8.1048
10.1016/j.jacc.2007.07.054
10.1126/science.1164680
10.1016/j.bbrc.2006.01.181
10.3109/14653249.2012.677822
10.1096/fj.06-6769com
10.1177/153537020422900706
10.1016/j.mad.2007.12.002
10.1073/pnas.1408233111
10.1038/nature06969
10.1172/JCI23769
10.1016/S0140-6736(11)61590-0
10.1096/fj.08-126946
10.1016/j.stemcr.2013.07.005
10.1073/pnas.1214608110
10.1016/j.ijcard.2007.11.068
ContentType Journal Article
Copyright COPYRIGHT 2016 BioMed Central Ltd.
Copyright BioMed Central 2016
The Author(s). 2016
Copyright_xml – notice: COPYRIGHT 2016 BioMed Central Ltd.
– notice: Copyright BioMed Central 2016
– notice: The Author(s). 2016
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
5PM
DOI 10.1186/s13287-016-0343-y
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
ProQuest Health & Medical Collection (NC LIVE)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList
MEDLINE

Publicly Available Content Database


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1757-6512
ExternalDocumentID PMC4907285
4105961111
A468879125
27296220
10_1186_s13287_016_0343_y
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: ;
  grantid: KOLUMB Fellowship Program
– fundername: ;
  grantid: 12POST12050363; 14GRNT18970018
GroupedDBID ---
0R~
4.4
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFS
ACIHN
ACJQM
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
E3Z
EBD
EBLON
EBS
EJD
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ISR
ITC
KQ8
LK8
M1P
M7P
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
ROL
RPM
RSV
SBL
SOJ
SV3
TUS
UKHRP
-56
-5G
-BR
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c625t-44af6035931e4b77eefca9cd642db5c0246ea69dd4fa984ac5336b99ccaf65a03
IEDL.DBID 7X7
ISSN 1757-6512
IngestDate Thu Aug 21 14:05:23 EDT 2025
Fri Jul 25 11:54:46 EDT 2025
Tue Jun 17 22:05:06 EDT 2025
Tue Jun 10 21:05:15 EDT 2025
Fri Jun 27 05:47:24 EDT 2025
Thu May 22 21:24:15 EDT 2025
Thu Jan 02 22:23:17 EST 2025
Thu Apr 24 22:57:21 EDT 2025
Tue Jul 01 00:43:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Alkaline phosphatase
Adipose tissue
Reprogramming
Epicardium
Fibroblasts
Cardiomyocytes
Adipose-derived stem cells
Cardiogenesis
Mesenchymal stem cells
Pericardium
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c625t-44af6035931e4b77eefca9cd642db5c0246ea69dd4fa984ac5336b99ccaf65a03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
OpenAccessLink https://www.proquest.com/docview/1800876055?pq-origsite=%requestingapplication%
PMID 27296220
PQID 1800876055
PQPubID 2040189
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4907285
proquest_journals_1800876055
gale_infotracmisc_A468879125
gale_infotracacademiconefile_A468879125
gale_incontextgauss_ISR_A468879125
gale_healthsolutions_A468879125
pubmed_primary_27296220
crossref_citationtrail_10_1186_s13287_016_0343_y
crossref_primary_10_1186_s13287_016_0343_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-06-13
PublicationDateYYYYMMDD 2016-06-13
PublicationDate_xml – month: 06
  year: 2016
  text: 2016-06-13
  day: 13
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Stem cell research & therapy
PublicationTitleAlternate Stem Cell Res Ther
PublicationYear 2016
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References P Antonitsis (343_CR36) 2007; 6
LW van Laake (343_CR12) 2007; 1
Y Yamada (343_CR31) 2006; 342
HS Ip (343_CR53) 1994; 14
WC Lee (343_CR58) 2009; 133
G Iacobellis (343_CR26) 2010; 33
WY Huang (343_CR52) 1995; 155
WKZW Safwani (343_CR60) 2012; 11
CW Chen (343_CR49) 2013; 31
Z Chen (343_CR47) 2014; 14
HS Sacks (343_CR30) 2009; 94
Z Liu (343_CR32) 2010; 2010
MA Haniffa (343_CR63) 2009; 94
G Iacobellis (343_CR25) 2005; 2
EM Zeisberg (343_CR54) 2005; 115
B Zhou (343_CR70) 2011; 121
JJ Chong (343_CR42) 2011; 9
L Qian (343_CR62) 2012; 485
NS Asli (343_CR27) 2014; 2
S Makino (343_CR33) 1999; 103
O Caspi (343_CR10) 2007; 50
EM Winter (343_CR29) 2007; 64
BP Kruithof (343_CR55) 2006; 295
V Schejbal (343_CR66) 1989; 43
BC Knollmann (343_CR22) 2013; 112
P Hematti (343_CR64) 2012; 14
J Schlueter (343_CR56) 2006; 295
B Zhou (343_CR57) 2008; 454
S Lee (343_CR43) 2014; 15
N Naftali-Shani (343_CR69) 2013; 2
MC Hofmann (343_CR48) 1993; 23
B Balana (343_CR59) 2006; 16
D Corradi (343_CR65) 2004; 13
343_CR34
M Mollova (343_CR8) 2013; 110
C Grepin (343_CR40) 1997; 124
GV Silva (343_CR19) 2005; 111
WT Pu (343_CR38) 2004; 275
D Mozaffarian (343_CR1) 2015; 131
OS Beane (343_CR46) 2014; 9
M Corselli (343_CR51) 2010; 30
O Bergmann (343_CR5) 2009; 324
SR Ali (343_CR7) 2014; 111
TD Miller (343_CR3) 1995; 92
CL Cai (343_CR28) 2008; 454
J Nussbaum (343_CR13) 2007; 21
WD Rosamond (343_CR2) 2012; 125
SE Senyo (343_CR6) 2013; 493
G D'Ippolito (343_CR45) 1999; 14
K Malliaras (343_CR9) 2013; 5
JD Fu (343_CR24) 2013; 1
RR Makkar (343_CR17) 2012; 379
M Ieda (343_CR41) 2010; 142
R Bolli (343_CR18) 2011; 378
S Janssens (343_CR15) 2006; 367
JJ Chong (343_CR23) 2014; 13
X Wang (343_CR68) 2014; 5
MA Laflamme (343_CR11) 2005; 167
W Xu (343_CR61) 2004; 229
CE Murry (343_CR21) 2004; 428
K Yoshida (343_CR4) 1993; 22
CT Kuo (343_CR39) 1997; 11
M Dominici (343_CR37) 2006; 8
Q Qian (343_CR35) 2012; 21
T Dill (343_CR16) 2009; 157
JM Hare (343_CR14) 2012; 308
KH Grinnemo (343_CR20) 2006; 38
A Stolzing (343_CR44) 2008; 129
S Baglioni (343_CR67) 2009; 23
A Dellavalle (343_CR50) 2007; 9
21476855 - Stem Cells Dev. 2012 Jan;21(1):67-75
22136928 - Cell Stem Cell. 2011 Dec 2;9(6):527-40
23569106 - Circ Res. 2013 Mar 15;112(6):969-76; discussion 976
9136932 - Genes Dev. 1997 Apr 15;11(8):1048-60
23222518 - Nature. 2013 Jan 17;493(7432):433-6
19567523 - J Clin Endocrinol Metab. 2009 Sep;94(9):3611-5
18568026 - Nature. 2008 Jul 3;454(7200):109-13
10404011 - J Bone Miner Res. 1999 Jul;14(7):1115-22
9199365 - Development. 1997 Jun;124(12):2387-95
23255322 - EMBO Mol Med. 2013 Feb;5(2):191-209
22420957 - Circulation. 2012 Apr 17;125(15):1848-57
25541697 - PLoS One. 2014 Dec 26;9(12):e115963
16127147 - Am J Pathol. 2005 Sep;167(3):663-71
19109217 - Haematologica. 2009 Feb;94(2):258-63
22088800 - Lancet. 2011 Nov 26;378(9806):1847-57
16923606 - Cytotherapy. 2006;8(4):315-7
7935467 - Mol Cell Biol. 1994 Nov;14(11):7517-26
20691899 - Cell. 2010 Aug 6;142(3):375-86
25520374 - Circulation. 2015 Jan 27;131(4):e29-322
24528676 - BMC Cancer. 2014 Feb 14;14:90
17980256 - J Am Coll Cardiol. 2007 Nov 6;50(19):1884-93
15642764 - Circulation. 2005 Jan 18;111(2):150-6
15229356 - Exp Biol Med (Maywood). 2004 Jul;229(7):623-31
18201779 - Int J Cardiol. 2009 Apr 17;133(3):399-401
23302686 - Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1446-51
10074487 - J Clin Invest. 1999 Mar;103(5):697-705
18241911 - Mech Ageing Dev. 2008 Mar;129(3):163-73
24319660 - Stem Cell Reports. 2013 Aug 22;1(3):235-47
20805269 - Diabetes Care. 2010 Sep;33(9):e127; author reply e128
19342590 - Science. 2009 Apr 3;324(5923):98-102
23117550 - JAMA. 2012 Dec 12;308(22):2369-79
8409073 - J Am Coll Cardiol. 1993 Oct;22(4):984-97
19584303 - FASEB J. 2009 Oct;23(10):3494-505
17160070 - Cell Res. 2006 Dec;16(12):949-60
2813303 - Pneumologie. 1989 Sep;43(9):490-9
20453168 - Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1104-9
16488397 - Biochem Biophys Res Commun. 2006 Apr 7;342(2):662-70
22336189 - Lancet. 2012 Mar 10;379(9819):895-904
25420887 - BMC Cell Biol. 2014 Nov 25;15:42
7634446 - Circulation. 1995 Aug 1;92 (3):334-41
16753139 - Dev Biol. 2006 Jul 15;295(2):507-22
23165704 - Stem Cells. 2013 Feb;31(2):305-16
7721094 - Gene. 1995 Apr 3;155(2):219-23
16581700 - Ann Med. 2006;38(2):144-53
19383383 - Stem Cell Res. 2007 Oct;1(1):9-24
8386657 - Eur Urol. 1993;23(1):38-44; discussion 45
16413875 - Lancet. 2006 Jan 14;367(9505):113-21
21505261 - J Clin Invest. 2011 May;121(5):1894-904
22522929 - Nature. 2012 May 31;485(7400):593-8
17293855 - Nat Cell Biol. 2007 Mar;9(3):255-67
19249426 - Am Heart J. 2009 Mar;157(3):541-7
24080908 - J Am Heart Assoc. 2013 Sep 30;2(5):e000253
22221649 - J Negat Results Biomed. 2012 Jan 06;11:3
25087896 - Stem Cell Res. 2014 Nov;13(3 Pt B):654-65
24876275 - Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8850-5
16677627 - Dev Biol. 2006 Jul 15;295(2):546-58
16186852 - Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10 ):536-43
15034593 - Nature. 2004 Apr 8;428(6983):664-8
15556777 - Cardiovasc Pathol. 2004 Nov-Dec;13(6):313-6
22458957 - Cytotherapy. 2012 May;14(5):516-21
25084810 - Stem Cell Res Ther. 2014 Aug 01;5(4):92
15464586 - Dev Biol. 2004 Nov 1;275(1):235-44
17670726 - Interact Cardiovasc Thorac Surg. 2007 Oct;6(5):593-7
17284483 - FASEB J. 2007 May;21(7):1345-57
18480752 - Nature. 2008 Jul 3;454(7200):104-8
20414349 - J Biomed Biotechnol. 2010;2010:104296
15902305 - J Clin Invest. 2005 Jun;115(6):1522-31
17380310 - Cell Mol Life Sci. 2007 Mar;64(6):692-703
References_xml – volume: 16
  start-page: 949
  issue: 12
  year: 2006
  ident: 343_CR59
  publication-title: Cell Res
  doi: 10.1038/sj.cr.7310116
– volume: 454
  start-page: 109
  issue: 7200
  year: 2008
  ident: 343_CR57
  publication-title: Nature
  doi: 10.1038/nature07060
– volume: 9
  start-page: 527
  issue: 6
  year: 2011
  ident: 343_CR42
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2011.10.002
– volume: 131
  start-page: e29
  issue: 4
  year: 2015
  ident: 343_CR1
  publication-title: Circulation
  doi: 10.1161/CIR.0000000000000152
– volume: 111
  start-page: 150
  issue: 2
  year: 2005
  ident: 343_CR19
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000151812.86142.45
– volume: 6
  start-page: 593
  issue: 5
  year: 2007
  ident: 343_CR36
  publication-title: Interact Cardiovasc Thorac Surg
  doi: 10.1510/icvts.2007.157875
– volume: 14
  start-page: 90
  year: 2014
  ident: 343_CR47
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-90
– volume: 94
  start-page: 3611
  issue: 9
  year: 2009
  ident: 343_CR30
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2009-0571
– volume: 295
  start-page: 507
  issue: 2
  year: 2006
  ident: 343_CR55
  publication-title: Dev Biol
  doi: 10.1016/j.ydbio.2006.03.033
– volume: 1
  start-page: 9
  issue: 1
  year: 2007
  ident: 343_CR12
  publication-title: Stem Cell Res
  doi: 10.1016/j.scr.2007.06.001
– volume: 2
  start-page: 536
  issue: 10
  year: 2005
  ident: 343_CR25
  publication-title: Nat Clin Pract Cardiovasc Med
  doi: 10.1038/ncpcardio0319
– volume: 23
  start-page: 38
  issue: 1
  year: 1993
  ident: 343_CR48
  publication-title: Eur Urol
  doi: 10.1159/000474568
– volume: 308
  start-page: 2369
  issue: 22
  year: 2012
  ident: 343_CR14
  publication-title: JAMA
  doi: 10.1001/jama.2012.25321
– volume: 103
  start-page: 697
  issue: 5
  year: 1999
  ident: 343_CR33
  publication-title: J Clin Invest
  doi: 10.1172/JCI5298
– volume: 21
  start-page: 67
  issue: 1
  year: 2012
  ident: 343_CR35
  publication-title: Stem Cells Dev
  doi: 10.1089/scd.2010.0519
– volume: 124
  start-page: 2387
  issue: 12
  year: 1997
  ident: 343_CR40
  publication-title: Development
  doi: 10.1242/dev.124.12.2387
– volume: 2
  start-page: 117
  issue: 2
  year: 2014
  ident: 343_CR27
  publication-title: J Dev Biol
  doi: 10.3390/jdb2020117
– volume: 30
  start-page: 1104
  issue: 6
  year: 2010
  ident: 343_CR51
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.109.191643
– volume: 157
  start-page: 541
  issue: 3
  year: 2009
  ident: 343_CR16
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2008.11.011
– volume: 13
  start-page: 313
  issue: 6
  year: 2004
  ident: 343_CR65
  publication-title: Cardiovasc Pathol
  doi: 10.1016/j.carpath.2004.08.005
– volume: 33
  issue: 9
  year: 2010
  ident: 343_CR26
  publication-title: Diabetes Care
  doi: 10.2337/dc10-0904
– volume: 13
  start-page: 654
  issue: 3 Pt B
  year: 2014
  ident: 343_CR23
  publication-title: Stem Cell Res
  doi: 10.1016/j.scr.2014.06.005
– volume: 92
  start-page: 334
  issue: 3
  year: 1995
  ident: 343_CR3
  publication-title: Circulation
  doi: 10.1161/01.CIR.92.3.334
– volume: 367
  start-page: 113
  issue: 9505
  year: 2006
  ident: 343_CR15
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67861-0
– volume: 485
  start-page: 593
  issue: 7400
  year: 2012
  ident: 343_CR62
  publication-title: Nature
  doi: 10.1038/nature11044
– volume: 11
  start-page: 3
  year: 2012
  ident: 343_CR60
  publication-title: J Negat Results Biomed
  doi: 10.1186/1477-5751-11-3
– volume: 275
  start-page: 235
  issue: 1
  year: 2004
  ident: 343_CR38
  publication-title: Dev Biol
  doi: 10.1016/j.ydbio.2004.08.008
– volume: 2010
  start-page: 104296
  year: 2010
  ident: 343_CR32
  publication-title: J Biomed Biotechnol
– volume: 14
  start-page: 1115
  issue: 7
  year: 1999
  ident: 343_CR45
  publication-title: J Bone Miner Res
  doi: 10.1359/jbmr.1999.14.7.1115
– volume: 9
  issue: 12
  year: 2014
  ident: 343_CR46
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0115963
– volume: 155
  start-page: 219
  issue: 2
  year: 1995
  ident: 343_CR52
  publication-title: Gene
  doi: 10.1016/0378-1119(94)00893-W
– volume: 167
  start-page: 663
  issue: 3
  year: 2005
  ident: 343_CR11
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)62041-X
– volume: 38
  start-page: 144
  issue: 2
  year: 2006
  ident: 343_CR20
  publication-title: Ann Med
  doi: 10.1080/07853890500422982
– volume: 8
  start-page: 315
  issue: 4
  year: 2006
  ident: 343_CR37
  publication-title: Cytotherapy
  doi: 10.1080/14653240600855905
– ident: 343_CR34
  doi: 10.1007/978-1-60327-169-1_7
– volume: 9
  start-page: 255
  issue: 3
  year: 2007
  ident: 343_CR50
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1542
– volume: 15
  start-page: 42
  year: 2014
  ident: 343_CR43
  publication-title: BMC Cell Biol
  doi: 10.1186/s12860-014-0042-4
– volume: 14
  start-page: 7517
  issue: 11
  year: 1994
  ident: 343_CR53
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.14.11.7517
– volume: 125
  start-page: 1848
  issue: 15
  year: 2012
  ident: 343_CR2
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.047480
– volume: 142
  start-page: 375
  issue: 3
  year: 2010
  ident: 343_CR41
  publication-title: Cell
  doi: 10.1016/j.cell.2010.07.002
– volume: 94
  start-page: 258
  issue: 2
  year: 2009
  ident: 343_CR63
  publication-title: Haematologica
  doi: 10.3324/haematol.13699
– volume: 428
  start-page: 664
  issue: 6983
  year: 2004
  ident: 343_CR21
  publication-title: Nature
  doi: 10.1038/nature02446
– volume: 2
  issue: 5
  year: 2013
  ident: 343_CR69
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.113.000253
– volume: 31
  start-page: 305
  issue: 2
  year: 2013
  ident: 343_CR49
  publication-title: Stem Cells
  doi: 10.1002/stem.1285
– volume: 64
  start-page: 692
  issue: 6
  year: 2007
  ident: 343_CR29
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-007-6522-3
– volume: 5
  start-page: 92
  issue: 4
  year: 2014
  ident: 343_CR68
  publication-title: Stem Cell Res Ther
  doi: 10.1186/scrt481
– volume: 121
  start-page: 1894
  issue: 5
  year: 2011
  ident: 343_CR70
  publication-title: J Clin Invest
  doi: 10.1172/JCI45529
– volume: 493
  start-page: 433
  issue: 7432
  year: 2013
  ident: 343_CR6
  publication-title: Nature
  doi: 10.1038/nature11682
– volume: 295
  start-page: 546
  issue: 2
  year: 2006
  ident: 343_CR56
  publication-title: Dev Biol
  doi: 10.1016/j.ydbio.2006.03.036
– volume: 5
  start-page: 191
  issue: 2
  year: 2013
  ident: 343_CR9
  publication-title: EMBO Mol Med
  doi: 10.1002/emmm.201201737
– volume: 22
  start-page: 984
  issue: 4
  year: 1993
  ident: 343_CR4
  publication-title: J Am Coll Cardiol
  doi: 10.1016/0735-1097(93)90407-R
– volume: 379
  start-page: 895
  issue: 9819
  year: 2012
  ident: 343_CR17
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)60195-0
– volume: 112
  start-page: 969
  issue: 6
  year: 2013
  ident: 343_CR22
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.112.300567
– volume: 11
  start-page: 1048
  issue: 8
  year: 1997
  ident: 343_CR39
  publication-title: Genes Dev
  doi: 10.1101/gad.11.8.1048
– volume: 50
  start-page: 1884
  issue: 19
  year: 2007
  ident: 343_CR10
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2007.07.054
– volume: 324
  start-page: 98
  issue: 5923
  year: 2009
  ident: 343_CR5
  publication-title: Science
  doi: 10.1126/science.1164680
– volume: 342
  start-page: 662
  issue: 2
  year: 2006
  ident: 343_CR31
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.01.181
– volume: 14
  start-page: 516
  issue: 5
  year: 2012
  ident: 343_CR64
  publication-title: Cytotherapy
  doi: 10.3109/14653249.2012.677822
– volume: 21
  start-page: 1345
  issue: 7
  year: 2007
  ident: 343_CR13
  publication-title: FASEB J
  doi: 10.1096/fj.06-6769com
– volume: 229
  start-page: 623
  issue: 7
  year: 2004
  ident: 343_CR61
  publication-title: Exp Biol Med
  doi: 10.1177/153537020422900706
– volume: 129
  start-page: 163
  issue: 3
  year: 2008
  ident: 343_CR44
  publication-title: Mech Ageing Dev
  doi: 10.1016/j.mad.2007.12.002
– volume: 111
  start-page: 8850
  issue: 24
  year: 2014
  ident: 343_CR7
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1408233111
– volume: 43
  start-page: 490
  issue: 9
  year: 1989
  ident: 343_CR66
  publication-title: Pneumologie
– volume: 454
  start-page: 104
  issue: 7200
  year: 2008
  ident: 343_CR28
  publication-title: Nature
  doi: 10.1038/nature06969
– volume: 115
  start-page: 1522
  issue: 6
  year: 2005
  ident: 343_CR54
  publication-title: J Clin Invest
  doi: 10.1172/JCI23769
– volume: 378
  start-page: 1847
  issue: 9806
  year: 2011
  ident: 343_CR18
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)61590-0
– volume: 23
  start-page: 3494
  issue: 10
  year: 2009
  ident: 343_CR67
  publication-title: FASEB J
  doi: 10.1096/fj.08-126946
– volume: 1
  start-page: 235
  issue: 3
  year: 2013
  ident: 343_CR24
  publication-title: Stem Cell Reports
  doi: 10.1016/j.stemcr.2013.07.005
– volume: 110
  start-page: 1446
  issue: 4
  year: 2013
  ident: 343_CR8
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1214608110
– volume: 133
  start-page: 399
  issue: 3
  year: 2009
  ident: 343_CR58
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2007.11.068
– reference: 17980256 - J Am Coll Cardiol. 2007 Nov 6;50(19):1884-93
– reference: 22522929 - Nature. 2012 May 31;485(7400):593-8
– reference: 24876275 - Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8850-5
– reference: 15902305 - J Clin Invest. 2005 Jun;115(6):1522-31
– reference: 10404011 - J Bone Miner Res. 1999 Jul;14(7):1115-22
– reference: 15034593 - Nature. 2004 Apr 8;428(6983):664-8
– reference: 19109217 - Haematologica. 2009 Feb;94(2):258-63
– reference: 2813303 - Pneumologie. 1989 Sep;43(9):490-9
– reference: 21505261 - J Clin Invest. 2011 May;121(5):1894-904
– reference: 23222518 - Nature. 2013 Jan 17;493(7432):433-6
– reference: 19584303 - FASEB J. 2009 Oct;23(10):3494-505
– reference: 8409073 - J Am Coll Cardiol. 1993 Oct;22(4):984-97
– reference: 23569106 - Circ Res. 2013 Mar 15;112(6):969-76; discussion 976
– reference: 23302686 - Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1446-51
– reference: 19249426 - Am Heart J. 2009 Mar;157(3):541-7
– reference: 23165704 - Stem Cells. 2013 Feb;31(2):305-16
– reference: 17160070 - Cell Res. 2006 Dec;16(12):949-60
– reference: 16923606 - Cytotherapy. 2006;8(4):315-7
– reference: 7634446 - Circulation. 1995 Aug 1;92 (3):334-41
– reference: 22458957 - Cytotherapy. 2012 May;14(5):516-21
– reference: 24528676 - BMC Cancer. 2014 Feb 14;14:90
– reference: 15642764 - Circulation. 2005 Jan 18;111(2):150-6
– reference: 25520374 - Circulation. 2015 Jan 27;131(4):e29-322
– reference: 9136932 - Genes Dev. 1997 Apr 15;11(8):1048-60
– reference: 17380310 - Cell Mol Life Sci. 2007 Mar;64(6):692-703
– reference: 16581700 - Ann Med. 2006;38(2):144-53
– reference: 20805269 - Diabetes Care. 2010 Sep;33(9):e127; author reply e128
– reference: 20691899 - Cell. 2010 Aug 6;142(3):375-86
– reference: 21476855 - Stem Cells Dev. 2012 Jan;21(1):67-75
– reference: 16127147 - Am J Pathol. 2005 Sep;167(3):663-71
– reference: 22420957 - Circulation. 2012 Apr 17;125(15):1848-57
– reference: 25541697 - PLoS One. 2014 Dec 26;9(12):e115963
– reference: 17670726 - Interact Cardiovasc Thorac Surg. 2007 Oct;6(5):593-7
– reference: 18480752 - Nature. 2008 Jul 3;454(7200):104-8
– reference: 24319660 - Stem Cell Reports. 2013 Aug 22;1(3):235-47
– reference: 8386657 - Eur Urol. 1993;23(1):38-44; discussion 45
– reference: 16488397 - Biochem Biophys Res Commun. 2006 Apr 7;342(2):662-70
– reference: 18241911 - Mech Ageing Dev. 2008 Mar;129(3):163-73
– reference: 25084810 - Stem Cell Res Ther. 2014 Aug 01;5(4):92
– reference: 7935467 - Mol Cell Biol. 1994 Nov;14(11):7517-26
– reference: 20414349 - J Biomed Biotechnol. 2010;2010:104296
– reference: 19567523 - J Clin Endocrinol Metab. 2009 Sep;94(9):3611-5
– reference: 22221649 - J Negat Results Biomed. 2012 Jan 06;11:3
– reference: 17284483 - FASEB J. 2007 May;21(7):1345-57
– reference: 25087896 - Stem Cell Res. 2014 Nov;13(3 Pt B):654-65
– reference: 18568026 - Nature. 2008 Jul 3;454(7200):109-13
– reference: 9199365 - Development. 1997 Jun;124(12):2387-95
– reference: 25420887 - BMC Cell Biol. 2014 Nov 25;15:42
– reference: 15464586 - Dev Biol. 2004 Nov 1;275(1):235-44
– reference: 24080908 - J Am Heart Assoc. 2013 Sep 30;2(5):e000253
– reference: 17293855 - Nat Cell Biol. 2007 Mar;9(3):255-67
– reference: 23117550 - JAMA. 2012 Dec 12;308(22):2369-79
– reference: 16677627 - Dev Biol. 2006 Jul 15;295(2):546-58
– reference: 16186852 - Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10 ):536-43
– reference: 19342590 - Science. 2009 Apr 3;324(5923):98-102
– reference: 16753139 - Dev Biol. 2006 Jul 15;295(2):507-22
– reference: 16413875 - Lancet. 2006 Jan 14;367(9505):113-21
– reference: 23255322 - EMBO Mol Med. 2013 Feb;5(2):191-209
– reference: 22136928 - Cell Stem Cell. 2011 Dec 2;9(6):527-40
– reference: 15229356 - Exp Biol Med (Maywood). 2004 Jul;229(7):623-31
– reference: 7721094 - Gene. 1995 Apr 3;155(2):219-23
– reference: 20453168 - Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1104-9
– reference: 22336189 - Lancet. 2012 Mar 10;379(9819):895-904
– reference: 18201779 - Int J Cardiol. 2009 Apr 17;133(3):399-401
– reference: 15556777 - Cardiovasc Pathol. 2004 Nov-Dec;13(6):313-6
– reference: 10074487 - J Clin Invest. 1999 Mar;103(5):697-705
– reference: 22088800 - Lancet. 2011 Nov 26;378(9806):1847-57
– reference: 19383383 - Stem Cell Res. 2007 Oct;1(1):9-24
SSID ssj0000330064
Score 2.3027892
Snippet Acute myocardial infarction (MI) leads to an irreversible loss of proper cardiac function. Application of stem cell therapy is an attractive option for MI...
Background Acute myocardial infarction (MI) leads to an irreversible loss of proper cardiac function. Application of stem cell therapy is an attractive option...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 84
SubjectTerms Actinin - genetics
Actinin - metabolism
Adipocytes - cytology
Adipocytes - drug effects
Adipocytes - metabolism
Adult
Aged
Alkaline Phosphatase - genetics
Alkaline Phosphatase - metabolism
Antigens, CD - genetics
Antigens, CD - metabolism
Azacitidine - pharmacology
Biomarkers - metabolism
Cell differentiation
Cell Transdifferentiation
DNA Methylation - drug effects
Female
Fibroblasts - cytology
Fibroblasts - drug effects
Fibroblasts - metabolism
GATA4 Transcription Factor - genetics
GATA4 Transcription Factor - metabolism
Gene Expression
Growth
Heart cells
Heart Transplantation
Humans
Male
Middle Aged
Myocytes, Cardiac - cytology
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - metabolism
Nanog Homeobox Protein - genetics
Nanog Homeobox Protein - metabolism
Octamer Transcription Factor-3 - genetics
Octamer Transcription Factor-3 - metabolism
Omentum - cytology
Omentum - drug effects
Omentum - metabolism
Osteocytes - cytology
Osteocytes - drug effects
Osteocytes - metabolism
Pericardium - cytology
Pericardium - drug effects
Pericardium - metabolism
Primary Cell Culture
Stem cell research
Stem cells
Stem Cells - cytology
Stem Cells - drug effects
Stem Cells - metabolism
Transcription Factors - pharmacology
Troponin T - genetics
Troponin T - metabolism
Title Multipotency and cardiomyogenic potential of human adipose-derived stem cells from epicardium, pericardium, and omentum
URI https://www.ncbi.nlm.nih.gov/pubmed/27296220
https://www.proquest.com/docview/1800876055
https://pubmed.ncbi.nlm.nih.gov/PMC4907285
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96h-CL-G31XIMIghiu26Zp-iR3cscpeMjqweJLSJNUF27baneV_vfOpNl69eFeFpZMu-3OZL4y8xtCXlmnXeasY2YuCgb2WDJps5QJbeMUYlwXp9g7_OlcnF3wj8tsGRJuXSir3OlEr6htYzBHfjiXHj0tzrJ37U-GU6PwdDWM0LhJ9hG6DKU6X-ZjjiWGYB1MbjjMnEtx2EHwJbHWEsLolKesn5ij_5XyFas0rZi8YoJO75I7wXekRwOz75Ebrr5Pbg3TJPsH5I9vpm0b9IJ7qmtLjS82XfcNSMnKUL8EO_qSNhX1w_motnBB55gFQfztLEVYZ4rJ_I5i4wl17crfZLt-S1t_thO-4O0RvGGzXT8kF6cnX9-fsTBXgRmIdjaMc10JhO5L546Xee5cZXRhLIQitswMWG3htCis5ZUuJNcGXEJRFgUwuxKZjtNHZK9uaveEUJOkeW5KiCm543PpykIYa2NZAnFZlVVE4t3fq0wAHcfZF5fKBx9SqIEjCgvNkCOqj8ib8ZJ2QNy4jvgF8kwNTaPjblVHXID2LMB7i8hLT4FYFzUW03zX265TH74sJkSvA1HVwOMZHXoT4CURHmtCeTChhM1opss74VFBGXTqn-hG5PEgR-ObJRDciCSJI5JPJGwkQPjv6Uq9-uFhwHkR54nMnl7_k8_I7cSLO8JNHpC9za-tew5-1Kac-c0yI_vHJ-efFzOfjYDPxfG3v2pSIwg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEaIXxJtAoRYCISGiJrHjJAeEKqDapY8DtNLejGM7dKVuEsguVf4Uv5EZJ1kaDr31GHnixPZ4HvbMN4S8MlbZ2Brr61BkPujj1E9NzHyhTMDAx7UBw9zho2MxOeVfZvFsg_wZcmEwrHKQiU5Qm0rjGflumDr0tCCOP9Q_fawahberQwmNji0ObHsBLlvzfvoJ1vd1FO1_Pvk48fuqAr4GW3_pc64KgcB1LLQ8TxJrC60ybcAQN3msQWcJq0RmDC9UlnKlwSASeZbBUAsRq4BBvzfITVC8ATp7ySxZn-kEjKGK7y9Pw1TsNuDspRjbCW4748xvR-rvfyVwSQuOIzQvqbz9u-ROb6vSvY657pENW94nt7rqle0DcuGSd-sKre6WqtJQ7YJbF20FXDnX1DWBBDmnVUFdMUCqDLzQWN8A4_-2hiKMNMXLg4Ziogu19dx1slq8o7W7S-ofsHsEi1iuFg_J6bXM-COyWValfUKojliS6Bx8WG55mNo8E9qYIM2BOC_ywiPBML1S9yDnWGvjXDpnJxWyWxGJgW24IrL1yNv1K3WH8HEV8Q6umeySVNfSQe5xAdI6A2vRIy8dBWJrlBi880OtmkZOv30dEb3piYoKfk-rPhcCBolwXCPK7RElbH49bh6YR_bCp5H_topHHnd8tB5ZBM6UiKLAI8mIw9YECDc-binnZw52nGdBEqXx06s_uUNuT06ODuXh9PjgGdmKHOsj1OU22Vz-WtnnYMMt8xdu41Dy_bp36l-PhV2Z
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multipotency+and+cardiomyogenic+potential+of+human+adipose-derived+stem+cells+from+epicardium%2C+pericardium%2C+and+omentum&rft.jtitle=Stem+cell+research+%26+therapy&rft.au=Wystrychowski%2C+Wojciech&rft.au=Patlolla%2C+Bhagat&rft.au=Zhuge%2C+Yan&rft.au=Neofytou%2C+Evgenios&rft.date=2016-06-13&rft.pub=BioMed+Central+Ltd&rft.issn=1757-6512&rft.eissn=1757-6512&rft.volume=7&rft.issue=1&rft_id=info:doi/10.1186%2Fs13287-016-0343-y&rft.externalDocID=A468879125
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-6512&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-6512&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-6512&client=summon